Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26055053 | 0.98 | L3MBTL1 (0.43) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL26054474 | 0.98 | L3MBTL1 (0.43) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL27050502 | 0.97 | KDM4E (0.42) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL25966496 | 0.96 | L3MBTL1 (0.44) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL24696784 | 0.96 | GAA (0.38) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL26412975 | 0.96 | L3MBTL1 (0.44) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL25966527 | 0.96 | KDM4E (0.41) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL25473579 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL25473646 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1GAAMEN1 | |
| SCHEMBL24922983 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228496-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228496-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240237523-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240237523-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240032322-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING SAME | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240032322-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING SAME | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-4276925-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME | NIPPON STEEL Chemical & Material Co., Ltd. (JP) | 2023-11-15 | — | — | EP | disclosed |
| WO-2022255241-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | 日鉄ケミカル＆マテリアル株式会社 | 2022-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228496-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, WEE2, CTNNA1 | KDM4E 1781/4885ATM 4552/4885L3MBTL1 488/4885 |
| US-20240237523-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, OR51E2, WEE2 | KDM4E 1745/4885ATM 4378/4885L3MBTL1 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.